Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Rambam Health Care Campus.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT01562067
First received: March 21, 2012
Last updated: March 22, 2012
Last verified: March 2011

March 21, 2012
March 22, 2012
March 2012
April 2013   (final data collection date for primary outcome measure)
Sonographic characteristics of cervical tumors [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Sonographic characteristics of cervical tumors indices measures before and after oncological treatments may shed light on the patient's prognosis.
Same as current
Complete list of historical versions of study NCT01562067 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy
Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.

no editional information. see above

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples Without DNA
Description:

pap smear

Non-Probability Sample

women with cervical cancer during radiotherapy

Cancer
Device: ultrasound examination
ultrasound and doppler studies to evaluate size and vascularity of tumor during radiotherapy
Other Name: no other name
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Not yet recruiting
40
April 2014
April 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Cervical cancer patients intended to undergo chemotherapy or radiation, or both

Exclusion Criteria:

  • no exclusions
Female
18 Years to 70 Years
No
Israel
 
NCT01562067
125-11CTIL
No
Rambam Health Care Campus
Rambam Health Care Campus
Not Provided
Principal Investigator: amnon amit, md Rambam Health Care Campus
Rambam Health Care Campus
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP